Notice: Announcement of Merger Completion Report
On October 22, 2024, the Board of Directors of Puzzle AI Co., Ltd. and Doyoubi Co., Ltd. respectively resolved that (A) would absorb and merge with (B), succeeding its rights and o
Notice: Announcement of Bonus Stock Issue (Stock Split)
We hereby announce that the Board of Directors of Puzzle AI Co., Ltd., at a meeting held on November 29, 2024, resolved to issue new shares through a bonus issue (capitalization of
Digitizing Catholic University of Korea Hospital Systems
Excerpt excerpt excerpt…
PuzzleAI wins Best Scientific Poster at AAO 2024
PuzzleAI’s new generative AI technology simplifies glaucoma diagnosis.
Transforming Medical Language Recognition: AI Solutions by PuzzleAI
Medical professionals in South Korea often mix medical terminology in Korean and English, creating a language that resembles an ‘alien language…
Notice: Submission of Creditor Objections Regarding Merger
On October 22, 2024, Puzzle AI Co., Ltd. (Party A) and Douyubi Co., Ltd. (Party B), in accordance with Articles 527-2 and 527-3 of the Commercial Act, have resolved at their respec
Notice: Announcement of Merger and Sovereignty Submission
On October 22, 2024, Puzzle AI Co., Ltd. and Douyubi Co., Ltd., in accordance with Article 527-2 and Article 527-3 of the Commercial Act, respectively, decided to merge...
Notice: Small Scale Merger
Our company hereby announces that it has entered into a small-scale merger agreement with DOUYOUBI Co., Ltd. through board approval in accordance with Article 527-3 of the Commerci
US Patent Granted for VoiceEMR Keyboard Macro Function
PuzzleAI announces a US patent for the VoiceEMR keyboard macro function, transforming healthcare interactions.
VoiceENR: Grand Prize Winner at iF Design Awards 2024
PuzzleAI Announces Grand Prize Win PuzzleAI, a leading medical artificial intelligence company, and Doyoubi, an innovative artificial intelligence startup, proudly announce th
